These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

933 related articles for article (PubMed ID: 19729084)

  • 1. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.
    Liang X; Bi S; Yang W; Wang L; Cui G; Cui F; Zhang Y; Liu J; Gong X; Chen Y; Wang F; Zheng H; Wang F; Guo J; Jia Z; Ma J; Wang H; Luo H; Li L; Jin S; Hadler SC; Wang Y
    Vaccine; 2009 Nov; 27(47):6550-7. PubMed ID: 19729084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprint of: Epidemiological serosurvey of Hepatitis B in China--declining HBV prevalence due to Hepatitis B vaccination.
    Liang X; Bi S; Yang W; Wang L; Cui G; Cui F; Zhang Y; Liu J; Gong X; Chen Y; Wang F; Zheng H; Wang F; Guo J; Jia Z; Ma J; Wang H; Luo H; Li L; Jin S; Hadler SC; Wang Y
    Vaccine; 2013 Dec; 31 Suppl 9():J21-8. PubMed ID: 23948229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in central China.
    Yonghao G; Jin X; Jun L; Pumei D; Ying Y; Xiuhong F; Yanyang Z; Wanshen G
    Int J Infect Dis; 2015 Nov; 40():75-80. PubMed ID: 26456567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014].
    Wang FZ; Zhang GM; Shen LP; Zheng H; Wang F; Miao N; Yuan QL; Sun XJ; Bi SL; Liang XF; Wang HQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):462-468. PubMed ID: 28592086
    [No Abstract]   [Full Text] [Related]  

  • 5. [The epidemiological characteristics of HBV susceptibility in 1-29 years old young people in China in 2006 and 2014: based on the national sero-survey data analysis].
    Zheng H; Wang FZ; Zhang GM; Miao N; Sun XJ; Cui FQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):581-586. PubMed ID: 28693080
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of hepatitis B vaccination among children in Guangdong Province, China.
    Xiao J; Zhang J; Wu C; Shao X; Peng G; Peng Z; Ma W; Zhang Y; Zheng H
    Int J Infect Dis; 2012 Sep; 16(9):e692-6. PubMed ID: 22795176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination.
    Zhang L; Xu A; Yan B; Song L; Li M; Xiao Z; Xu Q; Li L
    Int J Infect Dis; 2010 Jun; 14(6):e483-8. PubMed ID: 19939719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan.
    Ni YH; Chang MH; Jan CF; Hsu HY; Chen HL; Wu JF; Chen DS
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1324-30. PubMed ID: 27155556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of hepatitis B virus infection and impact of vaccination.
    Huang P; Zhu LG; Zhu YF; Yue M; Su J; Zhu FC; Yang HT; Zhang Y; Shen HB; Yu RB; Zhai XJ; Peng ZH
    World J Gastroenterol; 2015 Jul; 21(25):7842-50. PubMed ID: 26167084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis B prevalence among women in child-bearing age in Shandong Province, China, 2014].
    Zhang L; Liu JY; Lyu JJ; Yan BY; Feng Y; Wu WL; Song LZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):475-479. PubMed ID: 28592088
    [No Abstract]   [Full Text] [Related]  

  • 11. [Seroepidemiological analysis of hepatitis B among children aged 1-14 in 3 counties of Guangdong province in 2013].
    Shao X; Wu C; Wang F; Liang J; Xie X; Zhu Q; Liu J; Hu P; Qiu Q; Liang X; Zheng H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):777-81. PubMed ID: 26733134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan.
    Khetsuriani N; Tishkova F; Jabirov S; Wannemuehler K; Kamili S; Pirova Z; Mosina L; Gavrilin E; Ursu P; Drobeniuc J
    Vaccine; 2015 Jul; 33(32):4019-24. PubMed ID: 26072015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of hepatitis B and immune response to hepatitis B vaccination in Chinese college students mainly from the rural areas of western China and born before HBV vaccination integrated into expanded program of immunization.
    Liao XY; Zhou ZZ; Wei FB; Qin HN; Ling Y; Li RC; Li YP; Nong Y; Sun KX; Li J; Zhuang H
    Hum Vaccin Immunother; 2014; 10(1):224-31. PubMed ID: 24018404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus in the Lao People's Democratic Republic: a cross sectional serosurvey in different cohorts.
    Black AP; Nouanthong P; Nanthavong N; Souvannaso C; Vilivong K; Jutavijittum P; Samountry B; Lütteke N; Hübschen JM; Goossens S; Quet F; Buisson Y; Muller CP
    BMC Infect Dis; 2014 Aug; 14():457. PubMed ID: 25149478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China].
    Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sero-epidemiological analysis on hepatitis B among children aged 1-14 years old born to HBsAg positive mother in China, 2014].
    Wang FZ; Zheng H; Zhang GM; Miao N; Sun XJ; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr; 38(4):457-461. PubMed ID: 28468062
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis-B virus infection in India: Findings from a nationally representative serosurvey, 2017-18.
    Murhekar MV; Santhosh Kumar M; Kamaraj P; Khan SA; Allam RR; Barde P; Dwibedi B; Kanungo S; Mohan U; Mohanty SS; Roy S; Sagar V; Savargaonkar D; Tandale BV; Topno RK; Girish Kumar CP; Sabarinathan R; Bitragunta S; Grover GS; Lakshmi PVM; Mishra CM; Sadhukhan P; Sahoo PK; Singh SK; Yadav CP; Kumar R; Dutta S; Toteja GS; Gupta N; Mehendale SM;
    Int J Infect Dis; 2020 Nov; 100():455-460. PubMed ID: 32896662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimization of hepatitis B infection among children in Jiangsu, China, 12years after integration of hepatitis B vaccine into the expanded program on immunization.
    Lin X; Yang J; Lu H; Zhou Y; Zhou G; Wu H; Xu C; Wu Q; Liu J; Chen S; Yang M; Gu G; Hu Y; Zhou YH
    Vaccine; 2016 Dec; 34(51):6458-6463. PubMed ID: 27866767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme.
    Shen LP; Zhang Y; Wang F; Zhang S; Yang JY; Fang KX; Yu T; Wang XY; Zhang WY; Bi SL
    Epidemiol Infect; 2011 Aug; 139(8):1159-65. PubMed ID: 21156099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological serosurvey of hepatitis B virus among children aged 1-14 years in Guangdong Province, China.
    Zhu Q; Shao X; Chen S; Li D; Chen X; Liu W; Wu X; Jian Z; Rutherford S; Zheng H
    Int J Infect Dis; 2018 Jun; 71():25-29. PubMed ID: 29408358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.